Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP3 | P42574 | 4/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | MDM4 | O15151 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | P2RY12 | Q9H244 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24963330 | 1.00 | CASP3 (0.41) | CASP3KMT2AMDM4TP53P2RY12 | |
| SCHEMBL24965940 | 0.91 | CASP3 (0.38) | CASP3KMT2AMDM4TP53P2RY12 | |
| SCHEMBL24965939 | 0.91 | CASP3 (0.38) | CASP3KMT2AMDM4TP53P2RY12 | |
| SCHEMBL22605622 | 0.90 | CASP3 (0.36) | CASP3 | |
| SCHEMBL26010142 | 0.88 | PRCP (0.35) | CASP3KMT2A | |
| SCHEMBL24966155 | 0.87 | CASP3 (0.41) | CASP3KMT2AMDM4TP53 | |
| SCHEMBL24966154 | 0.87 | CASP3 (0.41) | CASP3KMT2AMDM4TP53 | |
| SCHEMBL29696715 | 0.87 | CASP3 (0.48) | CASP3KMT2AMDM4TP53 | |
| SCHEMBL24966013 | 0.86 | CASP3 (0.39) | CASP3 | |
| SCHEMBL24966009 | 0.86 | CASP3 (0.39) | CASP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230026641-A1 | METHOD FOR PRODUCING PEPTIDE COMPOUND COMPRISING HIGHLY STERICALLY HINDERED AMINO ACID | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2023-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230026641-A1 | METHOD FOR PRODUCING PEPTIDE COMPOUND COMPRISING HIGHLY STERICALLY HINDERED AMINO ACID | DNPEP, VIP, NPEPPS | CASP3 1864/4885KMT2A 2469/4885MDM4 3528/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.